Regulation of immune responses by histone deacetylase inhibitors
about
Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytesThe Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyPD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.Histones: Controlling Tumor Signaling CircuitryPreoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation.Going back to class I: MHC and immunotherapies for childhood cancer.Epigenetic drugs: a novel anti-aging strategy?Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.Histone cleavage as a mechanism for epigenetic regulation: current insights and perspectives.The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors.Regulation of genes related to immune signaling and detoxification in Apis mellifera by an inhibitor of histone deacetylation.Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases.Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model.The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell typesEpigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses
P2860
Q27324527-282FF960-EE59-4549-95F2-CD629C6F290AQ28076473-3841A71F-A5F6-4ACF-B993-5816632C3B01Q33839204-5FF30E35-C180-4C1C-8A97-A3E6962E2B9CQ34109472-C5DBC476-8096-4A01-B193-0D527D961E90Q34432882-C47C52D5-C385-47A9-8672-5200729C1794Q34968517-668D86E8-C33B-437D-BB90-BAA14B2F1E09Q35117552-014A48C9-F354-4CD3-BED1-9A95CBDC669BQ36357400-C9111E7B-4ED7-41EC-86B0-9CC49067771AQ36525896-6FD57D54-8049-44FC-9EB2-D4C02AB6EE15Q36778660-B76CB3D4-7065-4973-AE19-1259D1308459Q37085681-4A8CC83E-4CC9-4868-B9A0-D08AAE6336F5Q37260765-B0C536D1-D474-477F-880D-68304AF23DC3Q37598556-86A338D7-13EB-438A-B3CC-A27E246D07BCQ40075215-61DDFF50-25F4-4CF7-BB13-CEE511C4F878Q41544554-D1A2D610-1163-4506-8371-4920E4EE277AQ42815246-13337720-1E40-48A8-A9C0-A176E447F4E5Q47417938-762B849B-E6E2-477A-8202-7990339B3BC3Q49853764-5B766EA3-836D-40A0-883A-F5ECB184DBFFQ50326769-1BB9F73C-F595-4E45-A0B3-A66D35AD5E4BQ58130496-8092A8AC-BBF3-4CC6-8703-50AC4469897CQ58572698-3E51789B-7738-4AB4-8B01-875A476A2512
P2860
Regulation of immune responses by histone deacetylase inhibitors
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Regulation of immune responses by histone deacetylase inhibitors
@ast
Regulation of immune responses by histone deacetylase inhibitors
@en
type
label
Regulation of immune responses by histone deacetylase inhibitors
@ast
Regulation of immune responses by histone deacetylase inhibitors
@en
prefLabel
Regulation of immune responses by histone deacetylase inhibitors
@ast
Regulation of immune responses by histone deacetylase inhibitors
@en
P2860
P356
P1433
P1476
Regulation of immune responses by histone deacetylase inhibitors
@en
P2093
Paul V Licciardi
Tom C Karagiannis
P2860
P304
P356
10.5402/2012/690901
P577
2012-03-18T00:00:00Z